104829-98-3

Basic information

• Product Name: 3-Amino-2-bromo-4,6-dimethylpyridine
• Synonyms: IFLAB-BB F1371-0213;2-BROMO-4,6-DIMETHYL-PYRIDIN-3-YLAMINE;AKOS BBS-00005796;3-AMINO-2-BROMO-4,6-DIMETHYLPYRIDINE;5-Amino-2-bromo-4,6-dimethylpyridine;2-bromo-4,6-dimethylpyridin-3-amine;3-Amino-2-bromo-4,6-dimethylpyridine ,98%;2-Bromo-4,6-dimethylpyridin-3-amine, 5-Amino-6-bromo-2,4-lutidine
• CAS NO: 104829-98-3
• Molecular Formula: C₇H₉BrN₂
• Molecular Weight: 201.06
• Product Categories: Heterocycles;Heterocyclic Compound;Pyridine series;Heterocyclic Compounds;Amines;Pyridines
• Mol File: 104829-98-3.mol
• Article Data: 8

Chemical Properties

• Melting Point: 61-62 °C
• Boiling Point: 304.805 °C at 760 mmHg
• Flash Point: 138.142 °C
• Appearance: /
• Density: 1.504 g/cm³
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.603
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 3.09±0.18(Predicted)
• CAS DataBase Reference: 3-Amino-2-bromo-4,6-dimethylpyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Amino-2-bromo-4,6-dimethylpyridine(104829-98-3)
• EPA Substance Registry System: 3-Amino-2-bromo-4,6-dimethylpyridine(104829-98-3)

Safety Data

• Hazard Codes: T
• Hazardous Substances Data: 104829-98-3(Hazardous Substances Data)

Usage

General Description

3-Amino-2-bromo-4,6-dimethylpyridine is a chemical compound with the molecular formula C7H9BrN2. It is a pyridine derivative with a bromine atom and two methyl groups attached to the 4 and 6 positions, and an amino group at the 3 position. 3-Amino-2-bromo-4,6-dimethylpyridine is commonly used as an intermediate in the synthesis of various pharmaceuticals, agrochemicals, and organic compounds. It is also used in the production of dyes, pigments, and other fine chemicals. 3-Amino-2-bromo-4,6-dimethylpyridine may have potential applications in the field of medicinal chemistry due to its structural properties and chemical reactivity. It is important to handle this compound with proper care and adhere to safety guidelines when working with it in laboratory settings.

InChI:InChI=1/C7H9BrN2/c1-4-3-5(2)10-7(8)6(4)9/h3H,9H2,1-2H3

Upstream product

• 1193-71-1 5-amino-2,4-dimethylpyridine 
• 140413-40-7 3-amino-2-chloro-4,6-dimethylpyridine 
• 610261-09-1 2-bromo-4,6-dimethylpyridine-3-carboxylic acid amide 
• 610279-99-7 4,6-dimethyl-3-cyano-2-bromopyridine 
• 769-28-8 2-hydroxy-4,6-dimethyl-3-carbonitrile 
• 123-54-6 acetylacetone 

Downstream Products

• 1062541-68-7 2-bromo-4,6-dimethyl-3-pyridinol 
• 1392469-35-0 2-(3-(4-methoxybenzyloxy)prop-1-ynyl)-4,6-dimethylpyridin-3-amine 
• 1392469-38-3 2-(3-(4-methoxybenzyloxy)propyl)-3-((Z)-dec-1-enyl)-4,6-dimethylpyridine 
• 1392469-39-4 3-(3-((Z)-dec-1-enyl)-4,6-dimethylpyridin-2-yl)propan-1-ol hydrochloride 
• 1392469-36-1 2-(3-(4-methoxybenzyloxy)propyl)-4,6-dimethylpyridin-3-amine 
• 1392469-37-2 2-(3-(4-methoxybenzyloxy)propyl)-3-bromo-4,6-dimethylpyridine 
• 757949-98-7 Raseglurant hydrochloride 
• 1417621-53-4 (E)-2-(3-(4-methoxybenzyloxy)propyl)-3-(dec-1-enyl)-4,6-dimethylpyridine 
• 104830-09-3 2-bromo-3-iodo-4,6-dimethylpyridine 

Relevant articles and documents

Anibamine and Its Analogues: Potent Antiplasmodial Agents from Aniba citrifolia

In our continuing search for novel natural products with antiplasmodial activity, an extract of Aniba citrifolia was found to have good activity, with an IC50 value less than 1.25 μg/mL. After bioassay-directed fractionation, the known indolizinium alkaloid anibamine (1) and the new indolizinium alkaloid anibamine B (2) were isolated as the major bioactive constituents, with antiplasmodial IC50 values of 0.170 and 0.244 μM against the drug-resistant Dd2 strain of Plasmodium falciparum. The new coumarin anibomarin A (3), the new norneolignan anibignan A (5), and six known neolignans (7-12) were also obtained. The structures of all the isolated compounds were determined based on analyses of 1D and 2D NMR spectroscopic and mass spectrometric data, and the absolute configuration of anibignan A (5) was assigned from its ECD spectrum. Evaluation of a library of 28 anibamine analogues (13-40) indicated that quaternary charged analogues had IC50 values as low as 58 nM, while uncharged analogues were inactive or significantly less active. Assessment of the potential effects of anibamine and its analogues on the intraerythrocytic stages and morphological development of P. falciparum revealed substantial activity against ring stages for compounds with two C-10 side chains, while those with only one C-10 side chain exhibited substantial activity against trophozoite stages, suggesting different mechanisms of action.

The potential role of anibamine, a natural product CCR5 antagonist, and its analogues as leads toward development of anti-ovarian cancer agents

Chemokines and their receptors play important roles in the development of primary tumors and their metastases. Particularly CC chemokine receptor 5 (CCR5) and its ligand CC chemokine ligand 5 (CCL5/RANTES) seem to be critical in proliferation and invasion of ovarian cancer, the leading cause of death from gynecological malignancies in the United States. Anibamine, the first natural product CCR5 antagonist, and its analogues were examined for their effects on proliferation of the OVCAR-3 ovarian cancer cells in order to validate their candidacy as leads to develop novel anti-ovarian cancer agents. Acting as CCR5 antagonists, anibamine and its analogues significantly suppressed CCL5-induced intracellular Ca2+ flux. The compounds also inhibited the proliferation of OVCAR-3 at micromolar to submicromolar range. Moreover, anibamine and several analogues did not show significant cytotoxicity in NIH 3T3 cells at concentrations up to 20 μM. Based on these results, anibamine and one of its synthetic analogues were defined as potential leads to develop novel agents against ovarian cancer.

Catalytic chain-breaking pyridinol antioxidants

(Chemical Equation Presented) The synthesis of 3-pyridinols carrying alkyltelluro, alkylseleno, and alkylthio groups is described together with a detailed kinetic, thermodynamic, and mechanistic study of their antioxidant activity. When assayed for their capacity to inhibit azo-initiated peroxidation of linoleic acid in a water/chlorobenzene two-phase system, tellurium-containing 3-pyridinols were readily regenerable by N-acetylcysteine contained in the aqueous phase. The best inhibitors quenched peroxyl radicals more efficiently than α-tocopherol, and the duration of inhibition was limited only by the availability of the thiol reducing agent. In homogeneous phase, inhibition of styrene autoxidation absolute rate constants kinh for quenching of peroxyl radical were as large as 1 x 107 M-1 s -1, thus outperforming the best phenolic antioxidants including α-tocopherol. Tellurium-containing 3-pyridinols could be quantitatively regenerated in homogeneous phase by N-tert-butoxycarbonyl cysteine methyl ester, a lipid-soluble analogue of N-acetylcysteine. In the presence of an excess of the thiol, a catalytic mode of action was observed, similar to the one in the two-phase system. Overall, compounds bearing the alkyltelluro moiety ortho to the OH group were much more effective antioxidants than the corresponding para isomers. The origin of the high reactivity of these compounds was explored using pulse-radiolysis thermodynamic measurements, and a mechanism for their unusual antioxidant activity was proposed. The tellurium-containing 3-pyridinols were also found to catalyze reduction of hydrogen peroxide in the presence of thiol reducing agents, thereby acting as multifunctional (preventive and chain-breaking) catalytic antioxidants.